Featured Slideset

HCV Expert Recap of AASLD 2008


Source: CCO Official Conference Coverage of the 2008 AASLD Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.


This downloadable slideset reviews the most clinically relevant new data on hepatitis C presented at the 2008 American Association for the Study of Liver Diseases Meeting.


Format: Microsoft PowerPoint (.ppt) | File size: 1.69 MB | Date posted: 11/19/2008


Slide topics include:

Browse Slides by Date - Descending

Slidesets 1 - 10 of 189

1  2  3  4  5  6  7  8  9  10  Next

HBV Patient Populations: Treating HBV in the Setting of Pregnancy


Source: HBV Providers’ Choice in Prime Time: Addressing Issues of Patient Populations, Resistance, Individualized Treatment, Management, and Efficacy


Download and review key data selected by Heiner Wedemeyer, MD, on HBV infection management in the setting of pregnancy and potential pregnancy. Use the slides in your own presentations!


Format: Microsoft PowerPoint (.ppt) | File size: 490 KB | Date posted: 11/11/2008


Slide topics include:

Management of Suboptimal Response


Source: HBV Providers’ Choice in Prime Time: Addressing Issues of Patient Populations, Resistance, Individualized Treatment, Management, and Efficacy


Download and review key data selected by Ching-Lung Lai, MD, on managing HBV patients with suboptimal responses, including consideration of definitions of response and management of partial response.


Format: Microsoft PowerPoint (.ppt) | File size: 484 KB | Date posted: 11/10/2008


Slide topics include:

Efficacy, Resistance, and Durability


Source: HBV Providers’ Choice in Prime Time: Addressing Issues of Patient Populations, Resistance, Individualized Treatment, Management, and Efficacy


Download and review key data selected by Stephen Locarnini, MD, PhD, FRC (Path), on the importance of initial HBV regimen efficacy in avoiding resistance and achieving durable responses.


Format: Microsoft PowerPoint (.ppt) | File size: 600 KB | Date posted: 11/10/2008


Slide topics include:

Cases in Point: Risk Factors, Surveillance Strategies, and Treatment Options for Hepatocellular Carcinoma


Source: Cases in Point: Risk Factors, Surveillance Strategies, and Treatment Options for Hepatocellular Carcinoma


Review monitoring and surveillance recommendations for HCC, and emerging strategies for treatment and management.


Format: Microsoft PowerPoint (.ppt) | File size: 2.40 MB | Date posted: 11/5/2008


Slide topics include:

New Measures of Treatment Success: Recent Data on Potency and On-Treatment Response


Source: Focus on the Virus: A New Paradigm for the Management and Treatment of HBV


Format: Microsoft PowerPoint (.ppt) | File size: 1.24 MB | Date posted: 10/18/2008


Slide topics include:

Viral Load and Disease Progression


Source: Focus on the Virus: A New Paradigm for the Management and Treatment of HBV


Format: Microsoft PowerPoint (.ppt) | File size: 1.52 MB | Date posted: 10/18/2008


Slide topics include:

Management of Resistance: Implications for Treatment Choices


Source: Focus on the Virus: A New Paradigm for the Management and Treatment of HBV


Format: Microsoft PowerPoint (.ppt) | File size: 1.27 MB | Date posted: 10/18/2008


Slide topics include:

New Management Strategies for HCV Nonresponders and Relapsers


Source: New Management Strategies for HCV Nonresponders and Relapsers


Format: Microsoft PowerPoint (.ppt) | File size: 1.05 MB | Date posted: 10/18/2008


Slide topics include:

Debate: What Is the Best Rescue Strategy for the Management of Primary Nonresponse: Switch or Add?


Source: Case Debates With the Experts: Applying the Updated Practice Guidelines to the Management of Hepatitis B


Robert G. Gish, MD, and Nezam H. Afdhal, MD, FRCPI, debate the optimal strategy for management of hepatitis B patients with primary nonresponse.


Format: Microsoft PowerPoint (.ppt) | File size: 588 KB | Date posted: 10/18/2008


Slide topics include:

Debate: What Is the Optimal Management Strategy for Lamivudine Resistance in HBeAg-Negative Patients?


Source: Case Debates With the Experts: Applying the Updated Practice Guidelines to the Management of Hepatitis B


Robert G. Gish, MD, and Robert P. Perrillo, MD, evaluate the best strategies for managing lamivudine resistance in patients with hepatitis B.


Format: Microsoft PowerPoint (.ppt) | File size: 680 KB | Date posted: 10/18/2008


Slide topics include:

Slidesets 1 - 10 of 189

1  2  3  4  5  6  7  8  9  10  Next

Featured Content

CCO Official 2008 AASLD Conference Coverage

Review official highlights of clinical significance from the annual AASLD meeting.

New Options for HCV Nonresponders

Join our experts as they review treatment options for patients with nonresponse to HCV therapy.

Update on Resistance to HBV and HCV Therapy

2008 Independent Conference Report on Hepatitis B and C Virus Resistance to Antiviral Therapies.